Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.72% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
TLSI · Jun 30, 2026
TriSalus Life Sciences, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-26-054275General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-88.80% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
1.73% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
36.86% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
86.78% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-86.03% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
27.50% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
22.93% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History9 statesHistory building
Sep 30, 20240/7 normalizedLevel 3Dec 31, 20240/7 normalizedLevel 3Mar 31, 20250/7 normalizedLevel 3Dec 31, 20240/8 normalizedAmended as filedJun 30, 20250/7 normalizedLevel 3Sep 30, 20250/8 normalizedLevel 3Dec 31, 20250/8 normalizedLevel 3Mar 31, 20260/8 normalizedLevel 3Jun 30, 20260/8 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 1.58%
- Current
- 0.72%
- Delta
- -0.87%
- Previous
- -72.82%
- Current
- -88.80%
- Delta
- -15.98%
- Previous
- -2.92%
- Current
- 1.73%
- Delta
- 4.65%
- Previous
- 42.45%
- Current
- 36.86%
- Delta
- -5.59%
- Previous
- 86.18%
- Current
- 86.78%
- Delta
- 0.60%
- Previous
- -94.52%
- Current
- -86.03%
- Delta
- 8.49%
- Previous
- 36.14%
- Current
- 27.50%
- Delta
- -8.64%
- Previous
- 27.78%
- Current
- 22.93%
- Delta
- -4.85%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Surgical & Medical Instruments & Apparatus peers →Has State · TriSalus Life Sciences, Inc. →Transitioned To · TLSI SBC_INTENSITY_DECREASED →Transitioned To · TLSI Fundamental State →Transitioned To · TLSI CAPEX_INTENSITY_DECREASED →Transitioned To · TLSI CASH_GENERATION_DECREASED →Transitioned To · TLSI GROWTH_INCREASED →Transitioned To · TLSI INVENTORY_PRESSURE_DECREASED →Transitioned To · TLSI MARGIN_INCREASED →Transitioned To · TLSI PROFITABILITY_INCREASED →Transitioned To · TLSI R_AND_D_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.